Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer's disease.
about
The Receptor for Advanced Glycation Endproducts is a mediator of toxicity by IAPP and other proteotoxic aggregates: Establishing and Exploiting Common Ground for Novel Amyloidosis Therapies.Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits.Intravenously Injected Amyloid-β Peptide With Isomerized Asp7 and Phosphorylated Ser8 Residues Inhibits Cerebral β-Amyloidosis in AβPP/PS1 Transgenic Mice Model of Alzheimer's Disease
P2860
Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer's disease.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer's disease.
@en
Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer's disease.
@nl
type
label
Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer's disease.
@en
Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer's disease.
@nl
prefLabel
Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer's disease.
@en
Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer's disease.
@nl
P2093
P2860
P1476
Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer's disease.
@en
P2093
Amritpal Mudher
Andrew Stephen Phillips
Christian Paul
Delphine Boche
Katie Gaimster
Maria Luisa Moro
P2860
P2888
P356
10.1186/S40478-017-0505-X
P577
2018-01-03T00:00:00Z
P6179
1100166806